Scientists have claimed that foetal immune cells that are present in adults have specialised roles during infection. In fact, the first immune cells made in early life are fast-acting first responders to microbes in adulthood.
According to the authors, these immune cells -- called CD8+ T cells -- originate in separate parts of the body and are hardwired with intrinsically different properties.
While currently it is believed that, around the time of birth, the body switches from making and using foetal T cells to adult T cells to defend itself.
However, the researchers used a unique study design to show that foetal T cells persist into adulthood and have different roles than adult cells in fighting infection.
"This discovery has led to the new idea that we might be able to predict how individuals will respond to infection based on how many foetal cells are present in the adult pool and isolate the fast-acting foetal-derived cells for certain therapeutic interventions, such as infections and cancer immunotherapy," said lead author Brian Rudd from New York's Cornell University.
The findings, published in the journal Cell, showed that the newly formed T cells in adults recognise a signature protein on a pathogen when they first encounter it. That signal then activates the T cells and equips them to fight and proliferate up to 15 times, producing up to 10 million cells in a week.
Once the pathogen has been cleared, most of those adult T cells die, but up to 10 per cent survive and are stored in a pool of memory cells, allowing for a rapid recall response if that same pathogen were to strike again.
Foetal-derived cells, on the other hand, are generalists and do not form into memory cells. They respond to inflammatory signals and activate faster than adult T cells, allowing them to provide a broad swath of protection against pathogens they don't specifically recognise, Rudd said.
"It's the way that the immune system hedges its bet: It has cells that can respond at different rates," Rudd said.
--IANS
sh/rt/and/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
